All MEK-1 inhibitors approved by the FDA or in clinical trials inhibit major cytochromes

Published: 14 May 2020| Version 1 | DOI: 10.17632/9b7y3k7n3r.1
Contributor:
Tyler Beck

Description

Predictive pharmacokinetic data for every MEK-1 inhibitor approved by the FDA or in clinical trials.

Files

Institutions

Medical University of South Carolina - College of Graduate Studies

Categories

Pharmacokinetics

Licence